HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Yann Lecluse Selected Research
Yann Lecluse Research Topics
Disease
7
Neoplasms (Cancer)
01/2021 - 05/2005
2
Leukemia
01/2020 - 09/2014
1
Disease Progression
11/2019
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2019
1
Hypoxia (Hypoxemia)
03/2009
1
Melanoma (Melanoma, Malignant)
12/2008
1
Familial ependymoma
07/2008
1
Brain Neoplasms (Brain Tumor)
07/2008
1
Ependymoma
07/2008
1
Glioma (Gliomas)
07/2008
1
Carcinogenesis
07/2008
1
Neuroblastoma
09/2007
1
Polycythemia Vera
09/2006
Drug/Important Bio-Agent (IBA)
2
Erythropoietin
FDA Link
09/2007 - 09/2006
1
Vincristine (Oncovin)
FDA Link
Generic
01/2020
1
trametinib
IBA
01/2020
1
lorlatinib
IBA
11/2019
1
Crizotinib
IBA
11/2019
1
Anaplastic Lymphoma Kinase
IBA
11/2019
1
Thrombopoietin (c-mpl Ligand)
IBA
09/2014
1
DNA (Deoxyribonucleic Acid)
IBA
03/2009
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
03/2009
1
Granzymes (Granzyme)
IBA
03/2009
1
MART-1 Antigen
IBA
12/2008
1
Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)
IBA
12/2008
1
Biomarkers (Surrogate Marker)
IBA
09/2008
1
ErbB Receptors (EGF Receptor)
IBA
07/2008
1
Gefitinib (Iressa)
FDA Link
07/2008
1
Tyrosine Kinase Inhibitors
IBA
07/2008
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
07/2008
1
Biological Products
IBA
09/2006
1
Interferons
IBA
02/2006
Therapy/Procedure
1
Immunotherapy
01/2021
1
Drug Therapy (Chemotherapy)
01/2020
1
Radiotherapy
07/2008
1
Therapeutics
07/2008
1
Injections
05/2005